The senior manager group consolidation is a global finance role within the Group Consolidation team. The role serves as a finance specialist, working with the global consolidation team to deliver monthly consolidated financial results for external and management reporting purposes, while also supporting projects required to meet reporting compliance requirements. By consolidating financial data, the role ensures that accurate and reliable information is provided to the business to support performance management and decision-making. As part of a team of accounting professionals, the role contributes to maintaining high-quality financial reporting.
Why Sandoz?
Sandoz is the global leader in Biosimilar and Generic medicines, a segment of the healthcare industry that delivers 80% of the world’s medicines at 30% of the cost, touching the lives of more than 1 billion people across 100+ countries! While we are proud of our achievements, we have an ambition to do more so that everyone can achieve the basic human right of good health.
With investments in new development capabilities, production sites, new acquisitions, and partnerships, we have the opportunity to shape the future of Sandoz and help even more people gain access to low-cost, high-quality medicines, sustainably.
Our momentum is powered by an open, collaborative culture driven by our talented and ambitious colleagues, who, in return for applying their skills, experience an agile and collegiate environment with impactful careers, where diversity of thought is welcomed and where personal growth is supported!
Join us, help us make healthcare fairer and faster.
We are committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
Compliance And Controls, Critical Thinking, Data Cleansing / Normalization, E2E Process View, Embracing Change, Financial Accounting, Financial And Management Reporting, Interpersonal Savvy, Resilience, Tax

Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients.
More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer.
Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion.
Read our community engagement guidelines: http://bit.ly/4ofoggc